查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1995170

关节镜市场：依产品类型、病患类型、应用程式和最终用户划分－2026-2032年全球市场预测

Arthroscopy Market by Product Type, Patient Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年关节镜市值为 66.5 亿美元，预计到 2026 年将成长至 69.8 亿美元，复合年增长率为 5.14%，到 2032 年将达到 94.5 亿美元。

主要市场统计数据
基准年 2025 66.5亿美元
预计年份：2026年 69.8亿美元
预测年份 2032 94.5亿美元
复合年增长率 (%) 5.14%

本导言部分深入探讨了临床实践、医疗设备创新和医疗保健服务模式如何融合，从而重新定义现代关节镜的结果。

由于微创器械、影像清晰度和手术全期系统整合技术的进步，关节镜已从一种小众手术方式发展成为整形外科和运动医学诊疗流程中不可或缺的重要组成部分。由于关节镜手术具有组织保留性好、恢復快、感染风险低等优点，临床医生现在通常更倾向于选择关节镜技术而非开放性手术。为此，医疗设备开发商和医疗系统正优先研发能够提高手术精度并减少手术操作差异的创新技术。

数位视觉化技术的进步、向门诊护理的转变以及对价值驱动方法的需求，如何共同改变关节镜手术实践和医疗设备。

在关节镜手术领域，变革正在发生，其驱动力包括技术融合、门诊治疗模式的转变以及外科医生对整合系统的日益增长的需求。成像和视觉化技术已超越单纯的光学性能，发展到涵盖数位扩展和连接功能，从而实现术中资料收集、远端协作以及与医院资讯系统的兼容。这些功能正在改变外科医生的工作流程，并催生对模组化系统的需求，这种系统无需更换整个平台即可进行升级。

评估美国关税趋势将如何影响整个关节镜系统的供应链、筹资策略和采购实践。

美国预计将征收的关税可能会影响关节镜供应链、筹资策略以及进口零件和成品的成本趋势。依赖跨境生产来製造关节镜、刨削器、泵浦或高频发生器的製造商将直接受到投入成本变化的影响，被迫重新评估供应商合约并考虑近岸外包方案以降低风险。为此，采购团队正在评估替代供应商、调整库存策略并探索区域製造伙伴关係，以维持获利能力。

将产品架构、患者人口统计特征、解剖结构适应性以及最终用户方面的差异与策略性产品和服务决策联繫起来的关键细分洞察。

对产品细分的详细分析揭示了植入、器械和系统在研发和临床需求模式上的差异。植入在材料科学和固定方法方面不断发展，以满足对耐用性和生物相容性的期望。器械种类繁多，从常用配件到先进的关节镜、泵、射频探头和刨削器，应有尽有，这些器械必须与外科医生的技术和视觉化平台无缝整合。系统则是一个独特的类别，专注于流体管理、射频平台和视觉化解决方案，这些共同构成了现代关节镜手术技术的基础。

美洲、欧洲、中东和非洲以及亚太地区的采用趋势、监管协调和区域因素如何影响商业策略。

区域趋势对整个关节镜领域的应用模式、监管环境和投资重点都有显着影响。在美洲，完善的报销机制、丰富的经验丰富的关节镜医生资源以及不断完善的门诊医疗基础设施，推动了对高效系统的需求，这些系统能够提供可预测的治疗效果并支持更高的手术容量。在该地区营运的市场参与企业必须在创新、注重成本的采购週期以及严格的临床数据要求之间取得平衡。

模组化平台、与治疗结果挂钩的服务模式以及优先考虑临床合作的竞争策略是确保长期采用的关键要素。

关节镜领域的主要企业正着力于几项策略重点：系统互通性、全生命週期服务交付以及产生支持临床价值的证据。他们正投资于模组化平台，以实现可视化、流体管理或能量输送组件的分阶段升级，从而降低医疗机构设备现代化的门槛。服务模式正从被动维护向主动支持和基于结果的合约转变，将供应商奖励与手术效率和患者康復指标挂钩。

为製造商和医疗保健提供者提供切实可行的建议，以增强韧性、加快临床部署，并使价值提案与医疗保健服务优先事项保持一致。

行业领导者应采取多管齐下的策略，以增强韧性、支持临床部署，并使商业模式与不断变化的医疗服务需求保持一致。首先，应优先考虑模组化设计和开放式架构，以实现分阶段升级并降低买方的整体拥有成本 (TCO)。这种方法可以降低部署门槛，延长已部署设备的使用寿命，并扩大相关产品和耗材的交叉销售机会。

采用透明且多方面的调查方法，结合监管审查、临床文献、相关人员访谈和技术产品评估来支持结论。

本研究途径结合了对公开监管文件、同行评审临床文献和医疗设备认证通知的系统性回顾，以及对外科、采购和经营团队等相关相关人员的重点访谈。在评估医疗设备技术时，我们根据技术规格、产品描述和供应商资讯披露的信息，整理了功能集和互通性特征。监管和政策分析纳入了近期发布的指导意见和关税公告，以评估其对供应链和跨境贸易的潜在影响。

一项横断面趋势整合研究突显了关节镜。

总之，关节镜正处于技术成熟与医疗服务模式变革的交会点。视觉化、液体管理和器械技术的进步使得手术更加精准高效，而向门诊治疗和价值主导采购的转变正在重塑采购逻辑。供应链的脆弱性和政策的转变加速了对製造地和产品架构的考量，而竞争优势也越来越依赖服务模式、训练系统和可验证的临床价值。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：关节镜市场：依产品类型划分

  • 植入
  • 装置
    • 配件
    • 关节镜
    • 泵浦
    • 高频探头
    • 刮鬍刀
  • 系统
    • 体液管理系统
    • 射频系统
    • 视觉化系统

第九章：依患者类型关节镜市场

  • 成人
  • 儿童

第十章：关节镜市场：依应用领域划分

  • 踝
  • 弯头
  • 髋关节
  • 膝盖
  • 肩膀
  • 手腕

第十一章：关节镜市场：依最终用户划分

  • 门诊手术中心
  • 医院和诊所

第十二章：关节镜市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：关节镜市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：关节镜市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国关节镜市场

第十六章：中国关节镜市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Arthrex Inc.
  • Auxein Medical
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bioventus, LLC
  • Boston Scientific Corporation
  • CONMED Corporation
  • Endoch Medical
  • Endomed Systems GmbH
  • Flexion Therapeutics Inc.
  • GPC Medical Ltd.
  • Hyalex Orthopaedics, Inc.
  • Johnson & Johnson Services Inc.
  • Karl Storz SE & Co. KG
  • MJ Surgical
  • Medtronic plc
  • Mercator Medical SA
  • Norm Medical
  • Olympus Corporation
  • Richard Wolf GmbH
  • Shagun Cares Inc.
  • Sklar Surgical Instruments
  • Smith & Nephew plc
  • Stryker Corporation
  • Visakha Healthcare India Pvt Ltd
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-EC2E133E341A

The Arthroscopy Market was valued at USD 6.65 billion in 2025 and is projected to grow to USD 6.98 billion in 2026, with a CAGR of 5.14%, reaching USD 9.45 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.65 billion
Estimated Year [2026] USD 6.98 billion
Forecast Year [2032] USD 9.45 billion
CAGR (%) 5.14%

An incisive introduction to how clinical practice, device innovation, and care delivery models are converging to redefine contemporary arthroscopy outcomes

Arthroscopy has evolved from a niche surgical approach into a foundational component of orthopedic and sports medicine care pathways, driven by advances in minimally invasive tools, visualization fidelity, and perioperative systems integration. Clinicians now routinely favor arthroscopic techniques where tissue-sparing access offers faster recovery and lower infection risk compared with open procedures, which has prompted device developers and health systems to prioritize innovations that enhance precision and reduce procedure variability.

Consequently, investment in arthroscopy spans hardware improvements, such as next-generation scopes and shavers, and procedural ecosystems, including fluid management and radiofrequency systems that stabilize the surgical field. Concurrently, training, reimbursement structures, and outpatient facility capabilities are shifting to support higher volumes of short-stay procedures, thereby reshaping clinical workflows and capital allocation. As this section unfolds, readers will gain a concise orientation to the forces influencing device design, clinical adoption, and the evolving interplay between technology and care delivery in arthroscopic practice.

How digital visualization advances, outpatient migration, and value-based imperatives are jointly transforming arthroscopy practice and device requirements

The landscape of arthroscopy is experiencing transformative shifts driven by technological convergence, procedural migration to outpatient settings, and heightened surgeon expectations for integrated systems. Imaging and visualization have moved beyond improved optics to include digital augmentation and connectivity that enable intraoperative data capture, remote collaboration, and compatibility with hospital information systems. These capabilities are altering surgeon workflows and creating demand for modular systems that can be upgraded without replacing entire platforms.

At the same time, health care delivery trends are accelerating the transition of elective arthroscopic procedures into ambulatory environments, prompted by cost containment pressures and patient preference for reduced exposure and faster recovery. This shift reinforces the need for compact, portable, and robust instrumentation as well as simplified sterilization and disposable options. Additionally, the emphasis on value-based care has intensified scrutiny of implant selection and procedural efficiency, encouraging manufacturers to demonstrate clear clinical benefits and streamlined supply chain solutions. Taken together, these transformative shifts are raising the bar for interoperability, lifecycle support, and evidence-based design, compelling stakeholders across surgical departments, ambulatory centers, and device companies to align investments with the new standard of care.

Assessment of how potential United States tariff developments could reshape supply chains, sourcing strategies, and procurement behavior across the arthroscopy ecosystem

Prospective tariff measures introduced by the United States can influence arthroscopy supply chains, sourcing strategies, and cost dynamics for imported components and finished devices. Manufacturers that rely on cross-border manufacturing for scopes, shavers, pumps, or radiofrequency generators face a direct impact on input costs, prompting reassessment of supplier contracts and consideration of nearshoring options to mitigate exposure. In response, procurement teams are evaluating alternative sourcing, adjusting inventory policies, and exploring regional manufacturing partnerships to preserve margin stability.

Beyond direct cost pressures, tariffs can accelerate broader strategic shifts. Device companies are likely to prioritize design for manufacturability to reduce reliance on tariff-sensitive components and to increase the use of standardized parts across product families. Meanwhile, hospitals and ambulatory centers may reassess total cost of ownership when selecting systems, favoring vendors that offer bundled service agreements or local support networks that absorb some logistical uncertainty. Importantly, regulatory alignment and customs facilitation become critical factors for exporters aiming to preserve market access, while policy uncertainty itself may slow capital purchases until tariff trajectories are clearer. Thus, the cumulative effect of tariffs extends beyond price effects to influence sourcing resilience, product architecture, and commercial strategies across the value chain.

Key segmentation insights linking product architecture, patient cohorts, anatomical applications, and end user distinctions to strategic product and service decisions

A granular view of product segmentation reveals differentiated development and clinical demand patterns across implants, instruments, and systems. Implants continue to evolve in material science and fixation methods to meet durability and biocompatibility expectations. Instruments encompass a spectrum from common accessories to sophisticated arthroscopes, pumps, radiofrequency probes, and shavers that must integrate seamlessly with surgeon technique and visualization platforms. Systems represent a distinct category focused on fluid management, radiofrequency platforms, and visualization solutions that together form the procedural backbone for modern arthroscopy.

Patient segmentation highlights divergent clinical pathways and device requirements between adult and pediatric populations, with pediatric care emphasizing size-adapted instrumentation, lower-profile scopes, and specific procedural protocols to protect growth plates and long-term function. Application-based differentiation spans anatomical focus areas such as ankle, elbow, hip, knee, shoulder, and wrist, each with unique instrumentation demands, ergonomic considerations, and rehabilitation protocols that influence device design and service offerings. End user segmentation identifies ambulatory surgery centers and hospitals and clinics as distinct operating environments: ambulatory centers prioritize compact systems, streamlined turnover, and cost-effective disposables, while hospitals place greater value on high-capacity visualization platforms, comprehensive service agreements, and integration with broader perioperative infrastructure. Together, these segmentation lenses inform product roadmaps, clinical training programs, and commercial approaches that align with procedural complexity and care setting requirements.

Regional forces shaping adoption, regulatory alignment, and commercial strategy across the Americas, Europe Middle East & Africa, and Asia-Pacific environments

Regional dynamics exert a powerful influence on uptake patterns, regulatory pathways, and investment priorities across the arthroscopy landscape. In the Americas, established reimbursement frameworks, a large base of experienced arthroscopic surgeons, and growing ambulatory infrastructure drive demand for efficient systems that deliver predictable outcomes and support higher procedural throughput. Market participants operating in this region must balance innovation with cost-conscious procurement cycles and rigorous clinical data requirements.

Europe, Middle East & Africa presents a heterogeneous terrain where regulatory harmonization efforts coexist with pronounced country-level variability in hospital capabilities and payer models. In this region, adoption often hinges on demonstrating improved clinical outcomes and compatibility with existing hospital ecosystems, while emerging markets emphasize affordability and local service support. Asia-Pacific is characterized by rapid infrastructure investment, expanding surgical capacity, and a rising middle-class patient base seeking advanced orthopedic care. Local manufacturing and regulatory pathways are increasingly important here, and multinational suppliers frequently pursue partnerships, regional training centers, and tailored product configurations to capture diverse clinical needs and procurement behaviors.

Competitive company strategies that prioritize modular platforms, outcome-aligned service models, and clinical engagement to secure long-term adoption

Leading firms in the arthroscopy domain are converging on a few strategic priorities: system interoperability, lifecycle service offerings, and evidence generation to support clinical value. Companies are investing in modular platforms that allow incremental upgrades to visualization, fluid management, or energy delivery components, which reduces capital replacement barriers for health systems. Service models are evolving from reactive maintenance to predictive support and bundled outcomes-based agreements that align vendor incentives with procedural efficiency and patient recovery metrics.

Competitive differentiation also centers on training and surgeon engagement, with manufacturers expanding simulation-based training programs and proctor networks to accelerate adoption and procedural consistency. Partnerships between device developers and digital health providers aim to incorporate analytics and surgical documentation into clinical workflows, enabling longitudinal outcome tracking and quality improvement. Moreover, strategic alliances with regional distributors, contract manufacturing partners, and academic centers facilitate faster market entry and localized product validation, particularly in markets with unique regulatory or infrastructural challenges.

Actionable recommendations for manufacturers and health systems to strengthen resilience, accelerate clinical adoption, and align value propositions with care delivery priorities

Industry leaders should adopt a multi-pronged strategy that enhances resilience, supports clinical adoption, and aligns commercial models with evolving care delivery needs. First, prioritize modular design and open architecture to enable incremental upgrades and to reduce total cost of ownership for purchasers. This approach lowers barriers to adoption and extends the useful life of installed bases while increasing cross-sell opportunities for adjacent products and consumables.

Second, invest in robust training ecosystems and evidence generation, combining simulation-based curricula with real-world data collection to demonstrate comparative effectiveness and to build surgeon confidence. Third, diversify manufacturing and logistics footprints by exploring nearshoring, dual-sourcing, and strategic inventory buffers that mitigate tariff and supply chain disruptions. Fourth, expand service offerings into outcomes-linked agreements and predictive maintenance to capture recurring revenue and to deepen customer relationships. Finally, tailor regional strategies to account for reimbursement nuance, regulatory timelines, and facility capabilities, ensuring that product configurations and commercial models resonate with local clinical and economic priorities.

Transparent multi-source research methodology combining regulatory review, clinical literature, stakeholder interviews, and technical product assessments to underpin conclusions

The research approach combined a structured review of public regulatory documents, peer-reviewed clinical literature, and device approval notices with targeted primary interviews across surgical, procurement, and executive stakeholders. Device technology assessments relied on technical specifications, product monographs, and supplier disclosures to map feature sets and interoperability characteristics. Regulatory and policy analysis incorporated recent guidance and tariff announcements to assess potential implications for supply chains and cross-border trade.

Qualitative insights were derived from interviews with orthopedic surgeons, ambulatory center managers, and hospital procurement leads to validate use-case assumptions and to surface adoption barriers. Comparative analysis of regional infrastructure and reimbursement environments supported differential strategy recommendations. Throughout, data integrity was maintained by triangulating sources and documenting assumptions used in scenario planning, ensuring transparency in how evidence informed strategic conclusions and recommendations.

Synthesis of cross-cutting trends highlighting the interconnected imperatives of technology, service models, and regional adaptability in arthroscopy

In conclusion, arthroscopy sits at the intersection of technological maturation and care delivery transformation. Advances in visualization, fluid management, and instrumentation are enabling more precise, efficient procedures while outpatient migration and value-driven procurement are reshaping purchasing logic. Supply chain vulnerabilities and policy shifts are accelerating considerations around manufacturing footprint and product architecture, and competitive advantage increasingly depends on service models, training ecosystems, and demonstrable clinical value.

As stakeholders navigate this evolving environment, alignment between product development, clinical evidence generation, and commercial strategy will determine long-term success. Companies that focus on interoperability, regional adaptability, and outcome-oriented service offerings will be best positioned to meet clinician expectations and institutional procurement needs. The conclusions presented here synthesize cross-cutting trends to inform immediate strategic choices and to support longer-term planning for those engaged in arthroscopy device development and deployment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Arthroscopy Market, by Product Type

  • 8.1. Implants
  • 8.2. Instruments
    • 8.2.1. Accessories
    • 8.2.2. Arthroscopes
    • 8.2.3. Pumps
    • 8.2.4. Radiofrequency Probes
    • 8.2.5. Shavers
  • 8.3. Systems
    • 8.3.1. Fluid Management Systems
    • 8.3.2. Rf Systems
    • 8.3.3. Visualization Systems

9. Arthroscopy Market, by Patient Type

  • 9.1. Adults
  • 9.2. Pediatrics

10. Arthroscopy Market, by Application

  • 10.1. Ankle
  • 10.2. Elbow
  • 10.3. Hip
  • 10.4. Knee
  • 10.5. Shoulder
  • 10.6. Wrist

11. Arthroscopy Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Hospitals & Clinics

12. Arthroscopy Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Arthroscopy Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Arthroscopy Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Arthroscopy Market

16. China Arthroscopy Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arthrex Inc.
  • 17.6. Auxein Medical
  • 17.7. B. Braun Melsungen AG
  • 17.8. Baxter International Inc.
  • 17.9. Bioventus, LLC
  • 17.10. Boston Scientific Corporation
  • 17.11. CONMED Corporation
  • 17.12. Endoch Medical
  • 17.13. Endomed Systems GmbH
  • 17.14. Flexion Therapeutics Inc.
  • 17.15. GPC Medical Ltd.
  • 17.16. Hyalex Orthopaedics, Inc.
  • 17.17. Johnson & Johnson Services Inc.
  • 17.18. Karl Storz SE & Co. KG
  • 17.19. M J Surgical
  • 17.20. Medtronic plc
  • 17.21. Mercator Medical S.A.
  • 17.22. Norm Medical
  • 17.23. Olympus Corporation
  • 17.24. Richard Wolf GmbH
  • 17.25. Shagun Cares Inc.
  • 17.26. Sklar Surgical Instruments
  • 17.27. Smith & Nephew plc
  • 17.28. Stryker Corporation
  • 17.29. Visakha Healthcare India Pvt Ltd
  • 17.30. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTHROSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTHROSCOPY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTHROSCOPY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTHROSCOPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTHROSCOPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTHROSCOPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ARTHROSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ARTHROSCOPY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTHROSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTHROSCOPY MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTHROSCOPY MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTHROSCOPY MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTHROSCOPY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTHROSCOPY MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTHROSCOPY MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTHROSCOPY MARKET SIZE, BY ARTHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTHROSCOPY MARKET SIZE, BY ARTHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTHROSCOPY MARKET SIZE, BY ARTHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTHROSCOPY MARKET SIZE, BY PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTHROSCOPY MARKET SIZE, BY PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTHROSCOPY MARKET SIZE, BY PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTHROSCOPY MARKET SIZE, BY RADIOFREQUENCY PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTHROSCOPY MARKET SIZE, BY RADIOFREQUENCY PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTHROSCOPY MARKET SIZE, BY RADIOFREQUENCY PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTHROSCOPY MARKET SIZE, BY SHAVERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTHROSCOPY MARKET SIZE, BY SHAVERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTHROSCOPY MARKET SIZE, BY SHAVERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTHROSCOPY MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTHROSCOPY MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTHROSCOPY MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTHROSCOPY MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTHROSCOPY MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTHROSCOPY MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTHROSCOPY MARKET SIZE, BY RF SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTHROSCOPY MARKET SIZE, BY RF SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTHROSCOPY MARKET SIZE, BY RF SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTHROSCOPY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTHROSCOPY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTHROSCOPY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTHROSCOPY MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTHROSCOPY MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTHROSCOPY MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTHROSCOPY MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTHROSCOPY MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTHROSCOPY MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTHROSCOPY MARKET SIZE, BY ANKLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTHROSCOPY MARKET SIZE, BY ANKLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTHROSCOPY MARKET SIZE, BY ANKLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTHROSCOPY MARKET SIZE, BY ELBOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTHROSCOPY MARKET SIZE, BY ELBOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTHROSCOPY MARKET SIZE, BY ELBOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTHROSCOPY MARKET SIZE, BY HIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTHROSCOPY MARKET SIZE, BY HIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTHROSCOPY MARKET SIZE, BY HIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTHROSCOPY MARKET SIZE, BY KNEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTHROSCOPY MARKET SIZE, BY KNEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTHROSCOPY MARKET SIZE, BY KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTHROSCOPY MARKET SIZE, BY SHOULDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTHROSCOPY MARKET SIZE, BY SHOULDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTHROSCOPY MARKET SIZE, BY SHOULDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTHROSCOPY MARKET SIZE, BY WRIST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTHROSCOPY MARKET SIZE, BY WRIST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTHROSCOPY MARKET SIZE, BY WRIST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTHROSCOPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTHROSCOPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTHROSCOPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTHROSCOPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTHROSCOPY MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTHROSCOPY MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTHROSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ARTHROSCOPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ARTHROSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. GCC ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. G7 ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. G7 ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NATO ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. NATO ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ARTHROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES ARTHROSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA ARTHROSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA ARTHROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA ARTHROSCOPY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA ARTHROSCOPY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ARTHROSCOPY MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ARTHROSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ARTHROSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)